Opioid: Clinical Trials

3 trials for Opioid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Unknown 1
Phase 31Unknown 1

Follow Opioid: new trials by email Literature Review of Opioid trials Research Report on Opioid

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GLP-1R Agonist Treatment for Opioid Use Disorder
Semaglutide Pen Injector, Placebo - Opioid Use Disorder, Opioid Abuse and Addiction
Phase 2RecruitingMilton S. Hershey Medical Center2002025-01-272026-08-28
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
Preemptive flurbiprofen axetil, Postoperative flurbiprofen axetil, Patient-controlled analgesia pump - Esophageal Cancer, Perioperative Analgesia
Phase 2 / Phase 3UnknownCancer Institute and Hospital, Chinese Academy of Medical Sciences1022022-10-102025-03-20
Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray
Naloxone hydrochloride 20mg/ml - Gambling, Opioid
Phase 2CompletedFinnish Institute for Health and Welfare202017-02-142019-09-12

Narrower conditions

Behavior, Addictive (1)  ·  Chemically-Induced Disorders (1)  ·  Esophageal Neoplasms (1)  ·  Gambling (1)  ·  Mental Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Opioid-Related Disorders (1)  ·  Substance-Related Disorders (1)

Broader conditions

Behavior (2)  ·  Compulsive Behavior (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Esophageal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Impulsive Behavior (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Risk-Taking (1)

Interventions

Naloxone (1)  ·  semaglutide (1)

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Finnish Institute for Health and Welfare (1)  ·  Milton S. Hershey Medical Center (1)

Countries

China (1)  ·  Finland (1)  ·  United States (1)

Top investigators

Hannu Alho, Prof. (1)  ·  Jennifer Nyland, PhD (1)

Results publications

PMID 36130734, PMID 40502777, PMID 41168808

NIH funding

UH3DA050325 (1)